Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement
1. Aspire's BUZZ BOMB™ receives positive initial consumer feedback. 2. Product features rapid caffeine delivery via sublingual nano technology. 3. BUZZ BOMB™ aims to compete in the growing pre-workout market. 4. Aspire plans to launch BUZZ BOMB™ at major fitness conventions in August. 5. Future product launches are planned to leverage Aspire's unique delivery technology.